Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Pediatric Endocrinology and Metabolism

Editor-in-Chief: Kiess, Wieland

Ed. by Bereket, Abdullah / Cohen, Pinhas / Darendeliler, Feyza / Dattani, Mehul / Gustafsson, Jan / Luo, Feihong / Mericq, Veronica / Roth, Christian / Toppari, Jorma

Editorial Board Member: Battelino, Tadej / Buyukgebiz, Atilla / Cassorla, Fernando / Chrousos, George P. / Cutfield, Wayne / Fideleff, Hugo L. / Hershkovitz, Eli / Hiort, Olaf / LaFranchi, Stephen H. / Lanes M. D., Roberto / Mohn, Angelika / Root, Allen W. / Rosenfeld, Ron G. / Werther, George / Zadik, Zvi

12 Issues per year

IMPACT FACTOR 2016: 1.233

CiteScore 2016: 1.09

SCImago Journal Rank (SJR) 2016: 0.527
Source Normalized Impact per Paper (SNIP) 2016: 0.602

See all formats and pricing
More options …
Volume 26, Issue 9-10 (Oct 2013)


Virilization in two pre-pubertal children exposed to topical androgen

Danielle Nelson
  • Department of Pediatrics, Section of Community Pediatrics, University of Calgary, Calgary, Canada
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Josephine Ho
  • Corresponding author
  • Department of Pediatrics, Section of Pediatric Endocrinology, University of Calgary, Calgary, Canada
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Danièle Pacaud
  • Department of Pediatrics, Section of Pediatric Endocrinology, University of Calgary, Calgary, Canada
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ David Stephure
  • Department of Pediatrics, Section of Pediatric Endocrinology, University of Calgary, Calgary, Canada
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2013-05-24 | DOI: https://doi.org/10.1515/jpem-2013-0127


Androgen replacement therapy for male hypogonadism may be prescribed utilizing intramuscular, oral or more recently, topical formulations. With topical formulations, there is a risk of person-to-person transmission if appropriate precautions are not taken. We describe two cases of virilization in pre-pubertal children following passive transfer of paternal topical testosterone. A 21 month old male was referred with a 6 week history of pubic hair, phallic growth, and linear growth spurt. Genital examination revealed Tanner stage 2 pubic hair and Tanner stage 3 phallic development, which was discordant with the pre-pubertal testicular size (2 mL bilaterally). A 3 year 8 month old girl was referred for a 2 month history of increasing pubic hair development. Examination revealed Tanner stage 2 pubic hair and Tanner stage 1 breast development. Both of these patients had fathers who had been diagnosed with hypogonadism and were being treated with topical androgen gel therapy, which they applied to their arms and chest before bed. In addition, both patients often slept with their parents resulting in skin-to-skin contact. Investigations were consistent with gonadotropin independent virilization with both patients demonstrating elevated testosterone levels. Testosterone levels returned to normal pre-pubertal levels with no further development of secondary sexual characteristics following discontinuation of exposure to topical testosterone. Precautions must be taken to prevent person-to-person transfer of topical steroids. With the increasing popularity of topical steroids for the treatment of low testosterone, it is imperative that these therapies be prescribed and utilized judiciously to prevent harm, specifically gonadotropin-independent virilization.

Keywords: testosterone; topical; virilization


  • 1.

    Beas F, Vargas L, Spada RP, Merchak N. Pseudoprecocious puberty in infants caused by a dermal ointment containing estrogens. J Pediatr 1969;75:127–30.Google Scholar

  • 2.

    Saenz de Rodriguez CA, Bongiovanni AM, Conde de Borrego L. An epidemic of precocious development in Puerto Rican children. J Pediatr 1985;107:393–6.Google Scholar

  • 3.

    Tiwary CM. Premature sexual development in children following the use of estrogen- or placenta-containing hair products. Clin Pediatr (Phila) 1998;37:733–9.Google Scholar

  • 4.

    Weber WW, Grossman M, Thom JV, Sax J, Chan JJ, et al. Drug contamination with diethylstilbestrol. Outbreak of precocious puberty due to contaminated isonicocinic acid hydrazide (INH). N Engl J Med 1963;268:411–5.Google Scholar

  • 5.

    Zimmerman PA, Francis GL, Poth M. Hormone-containing cosmetics may cause signs of early sexual development. Mil Med 1995;160:628–30.Google Scholar

  • 6.

    Yu YM, Punyasavatsu N, Elder D, D’Ercole AJ. Sexual development in a two-year-old boy induced by topical exposure to testosterone. Pediatrics 1999;104:e23.Web of ScienceGoogle Scholar

  • 7.

    Kunz GJ, Klein KO, Clemons RD, Gottschalk ME, Jones KL. Virilization of young children after topical androgen use by their parents. Pediatrics 2004;114:282–4.Google Scholar

  • 8.

    Franklin SL, Geffner ME. Precocious puberty secondary to topical testosterone exposure. J Pediatr Endocrinol Metab 2003;16:107–10.PubMedGoogle Scholar

  • 9.

    Svoren BM, Wolfsdorf JI. Sexual development in a 21 month-old boy caused by testosterone contamination of a topical hydrocortisone cream. J Pediatr Endocrinol Metab 2005;18: 507–10.Google Scholar

  • 10.

    Lewis T, Goldstein I. Transfer of topical testosterone preparations to children or spouses. J Sex Med 2009;6: 2649–52.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 11.

    Stephen MD, Jehaimi CT, Brosnan PG, Yafi M. Sexual precocity in a 2-year-old boy caused by indirect exposure to testosterone cream. Endocr Pract 2008;14:1027–30.CrossrefGoogle Scholar

  • 12.

    Brachet C, Vermeulen J, Heinrichs C. Children’s virilization and the use of a testosterone gel by their fathers. Eur J Pediatr 2005;164:646–7.Google Scholar

  • 13.

    Bhowmick SK, Ricke T, Rettig KR. Sexual precocity in a 16-month-old boy induced by indirect topical exposure to testosterone. Clin Pediatr (Phila) 2007;46:540–3.Web of ScienceGoogle Scholar

  • 14.

    Cavender RK, Fairall M. Precocious puberty secondary to topical testosterone transfer: a case report. J Sex Med 2011;8:622–6.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 15.

    Basaria S, Wahlstrom JT, Dobs AS. Clinical review 138: anabolic-androgenic steroid therapy in the treatment of chronic diseases. J Clin Endocrinol Metab 2001;86:5108–17.Google Scholar

  • 16.

    Petak SM, Nankin HR, Spark RF, Swerdloff RS, Rodriguez-Rigau LJ, et al. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients – 2002 update. Endocr Pract 2002;8:440–56.PubMedGoogle Scholar

  • 17.

    Conway AJ, Handelsman DJ, Lording DW, Stuckey B, Zajac JD. Use, misuse and abuse of androgens. The Endocrine Society of Australia consensus guidelines for androgen prescribing. Med J Aust 2000;172:220–4.Google Scholar

  • 18.

    Cuzin B, Giuliano F, Jamin C, Legros JJ, Lejeune H, et al. [Investigation, treatment and surveillance of late-onset hypogonadism in males: the official guidelines of the International Society for the Study of the Aging Male (ISSAM) with comments]. Prog Urol 2004;14:1–14.Google Scholar

  • 19.

    Franklin SL. Effects of unintentional exposure of children to compounded transdermal sex hormone therapy. Pediatr Endocrinol Rev 2011;8:208–12.PubMedGoogle Scholar

  • 20.

    Kirschner MA. Hirsutism and virilism in women. Spec Top Endocrinol Metab 1984;6:55–93.PubMedGoogle Scholar

  • 21.

    Kathiresan AS, Carr BR, Attia GR. Virilization from partner’s use of topical androgen in a reproductive-aged woman. Am J Obstet Gynecol 2011;205:e3–4.Web of ScienceGoogle Scholar

  • 22.

    Merhi ZO, Santoro N. Postmenopausal virilization after spousal use of topical androgens. Fertil Steril 2007;87:976.e13–5.Web of ScienceGoogle Scholar

  • 23.

    Klugo RC, Cerny JC. Response of micropenis to topical testosterone and gonadotropin. J Urol 1978;119:667–8.Google Scholar

  • 24.

    Ahmed SR, Boucher AE, Manni A, Santen RJ, Bartholomew M, et al. Transdermal testosterone therapy in the treatment of male hypogonadism. J Clin Endocrinol Metab 1988;66:546–51.Google Scholar

  • 25.

    Wilson JD, Walker JD. The conversion of testosterone to 5 alpha-androstan-17 beta-ol-3-one (dihydrotestosterone) by skin slices of man. J Clin Invest 1969;48:371–9.Google Scholar

  • 26.

    Herman-Giddens ME, Sandler AD, Friedman NE. Sexual precocity in girls. An association with sexual abuse? Am J Dis Child 1988;142:431–3.Google Scholar

  • 27.

    Guthrie RD, Smith DW, Graham CB. Testosterone treatment for micropenis during early childhood. J Pediatr 1973;83:247–52.Google Scholar

  • 28.

    Soliman AT, AlLamki M, AlSalmi I, Asfour M. Congenital adrenal hyperplasia complicated by central precocious puberty: linear growth during infancy and treatment with gonadotropin-releasing hormone analog. Metabolism 1997;46:513–7.Google Scholar

  • 29.

    Husmann DA, Cain MP. Microphallus: eventual phallic size is dependent on the timing of androgen administration. J Urol 1994;152:734–9.Google Scholar

  • 30.

    McMahon DR, Kramer SA, Husmann DA. Micropenis: does early treatment with testosterone do more harm than good? J Urol 1995;154:825–9.Google Scholar

  • 31.

    Sutherland RS, Kogan BA, Baskin LS, Mevorach RA, Conte F, et al. The effect of prepubertal androgen exposure on adult penile length. J Urol 1996;156:783–7; discussion 787.Google Scholar

About the article

Corresponding author: Josephine Ho, Faculty of Medicine, Department of Pediatrics, Section of Pediatric Endocrinology, University of Calgary, Alberta Children’s Hospital, 2888 Shaganappi Trail NW, Calgary, T3B 6A8, Canada, Phone: +1-403-955-7819, Fax: +1-403-955-5001, E-mail:

Received: 2013-03-28

Accepted: 2013-04-18

Published Online: 2013-05-24

Published in Print: 2013-10-01

Citation Information: Journal of Pediatric Endocrinology and Metabolism, ISSN (Online) 2191-0251, ISSN (Print) 0334-018X, DOI: https://doi.org/10.1515/jpem-2013-0127.

Export Citation

©2013 by Walter de Gruyter Berlin Boston. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Emilio García García and Ignacio Jiménez Varo
Endocrinología, Diabetes y Nutrición (English ed.), 2017, Volume 64, Number 5, Page 278
Emilio García García and Ignacio Jiménez Varo
Endocrinología, Diabetes y Nutrición, 2017, Volume 64, Number 5, Page 278
Reactions Weekly, 2014, Volume 1517, Number 1, Page 172

Comments (0)

Please log in or register to comment.
Log in